KERYX BIOPHARMACEUTICALS INC 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Jan 31, 2017
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Sale
Common Stock
2017-01-30$4.65/sh−8,447$39,279→ 98,873 total
Footnotes (2)
- [F1]Sale of a total of 8,447 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 21,668 shares of restricted stock on January 27, 2017. Mr. Holmes had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 58,331 shares of restricted stock.